Skip to main content

Table 2 1-, 2-, 5-, and 10-year incidence of bone metastases by tumor type

From: Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States

Tumor type Incidence of bone metastases (%)
1-year (95% CI) 2-year (95% CI) 5-year (95% CI) 10-year (95% CI)
All tumor types combined (N = 382,733) 4.8 (4.7–4.8) 5.6 (5.5–5.6) 6.9 (6.8–7.0) 8.4 (8.3–8.5)
Breast (N = 137,720) 3.4 (3.3–3.5) 4.2 (4.1–4.3) 6.0 (5.8–6.1) 8.1 (7.9–8.3)
Prostate (N = 22,801) 18.0 (17.5–18.5) 20.4 (19.9–20.9) 24.5 (23.9–25.1) 29.2 (28.3–30.1)
Lung (N = 59,344) 10.4 (10.2–10.7) 11.5 (11.3–11.8) 12.4 (12.1–12.7) 12.9 (12.6–13.2)
Colorectal (N = 46,832) 1.0 (0.9–1.1) 1.4 (1.3–1.5) 2.1 (2.0–2.3) 2.7 (2.5–2.9)
Gastrointestinal (N = 32,874) 2.3 (2.1–2.5) 2.7 (2.6–2.9) 3.2 (3.0–3.4) 3.6 (3.3–3.8)
Gynecological (N = 21,075) 1.1 (0.9–1.2) 1.3 (1.2–1.5) 1.9 (1.7–2.1) 2.4 (2.1–2.7)
Malignant melanoma (N = 12,152) 1.6 (1.4–1.8) 2.0 (1.7–2.2) 2.5 (2.2–2.8) 3.0 (2.6–3.4)
Renal (N = 17,717) 5.8 (5.5–6.2) 6.9 (6.6–7.3) 8.4 (8.0–8.9) 9.9 (9.3–10.5)
All other tumors (N = 32,218) 2.0 (1.8–2.1) 2.5 (2.3–2.7) 3.2 (3.0–3.4) 3.9 (3.5–4.2)